Attract talent

MiNA Therapeutics



Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.


Add photos to showcase MiNA Therapeutics’s culture


Add MiNA Therapeutics’s values

Insider experiences

Share your experience of working at MiNA Therapeutics

Robin Wright
Chief Financial Officer
Peter Bains
Chief Business Officer
Troels Koch
SVP, Chemistry
Ilian Tchakov
VP, Clinical Development
Julia Vassiliadou
VP, Clinical Operations
Kevin Fettes
VP, CMC & Quality Operations
Nagy Habib
Head of R&D

Add your teams to show how people work together at MiNA Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.